19 Recruiting Studies Using Deucravacitinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Deucravacitinib
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are NaΓ―ve to Biologic Disease-modifying Anti-rheumatic Drugs
π Local Institution - 0197 β Gilbert, Arizona
Psoriatic Arthritis
View Study & Checklist βA Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
π Local Institution - 0077 β Scottsdale, Arizona
Lupus Erythematosus, Discoid
View Study & Checklist βA Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
π Local Institution - 0012 β Birmingham, Alabama
Systemic Lupus Erythematosus
View Study & Checklist βA Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)
π Alliance Dermatology and MOHS Center P C β Phoenix, Arizona
Plaque Psoriasis
View Study & Checklist βA Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
π Medical Dermatology Specialists β Phoenix, Arizona
Plaque Psoriasis
View Study & Checklist βA Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are NaΓ―ve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFΞ± Inhibitor Treatment
π Local Institution - 0149 β Mountain Brook, Alabama
Psoriatic Arthritis
View Study & Checklist βA Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active SjΓΆgren's Syndrome
π Local Institution - 0228 β Fullerton, California
SjΓΆgren's Syndrome
View Study & Checklist βA Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus
π Local Institution - 0063 β La Jolla, California
Systemic Lupus Erythematosus
View Study & Checklist βA Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
π Bristol-Meyers Squibb β Lawrenceville, New Jersey
Psoriasis
View Study & Checklist βDeucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
π UT Southwestern Medical Center β Dallas, Texas
Psoriatic Arthritis (PsA)
View Study & Checklist βUtilization of a Microdevice for Psoriasis and Atopic Dermatitis
π University of California, San Francisco β San Francisco, California
Psoriasis
View Study & Checklist βDeucravacitinib in the Treatment of Cicatricial Alopecias
π Icahn School of Medicine at Mount Sinai β New York, New York
Central Centrifugal Cicatricial Alopecia
View Study & Checklist βA Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
π Local Institution β Waltham, Massachusetts
Psoriasis
View Study & Checklist βLong-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
π Local Institution - 0088 β Birmingham, Alabama
Plaque Psoriasis
View Study & Checklist βA Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
π Local Institution - 0038 β Lancaster, California
Juvenile Psoriatic Arthritis
View Study & Checklist βA Study to Assess Deucravacitinib Safety in Pregnancy
π University of California San Diego β La Jolla, California
Psoriasis (PsO)
View Study & Checklist βA Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
π Instituto de Neumonologia Y Dermatologia β Ciudad Autonoma de Buenos Aires, Buenos Aires
Plaque Psoriasis
View Study & Checklist βA Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
π Local Institution - 0261 β Birmingham, Alabama
Plaque Psoriasis
View Study & Checklist βCorrection of Psoriatic T Cell Signatures by Deucravacitinib
π University of California, San Francisco β San Francisco, California
Psoriasis Vulgaris
View Study & Checklist β